AOD-9604 is a modified fragment of human growth hormone (amino acids 176-191) that stimulates lipolysis and inhibits fat formation without affecting blood sugar or IGF-1 levels
Key Research Areas for 5-Amino-1MQ NNMT enzyme inhibition assays IC50 characterisation, selectivity profiling, and 1-MNA production quantification NAD+ salvage pathway studies nicotinamide flux, NMN and NAD+ pool modulation in vitro SAM/SAH methyl-donor pathway research epigenetic methylation capacity and histone modification studies Adipocyte biology lipogenesis suppression, adipocyte size, white adipose mass, and lipid storage pathway studies SIRT1 and SIRT3 activation and downstream pathway research insulin sensitivity, gluconeogenesis, mitochondrial function Skeletal muscle function and sarcopenia pathway research muscle strength, endurance, and mitophagy-related studies in aged models Gut microbiome modulation research in diet-induced obesity models Cancer cell biology NNMT-overexpressing cell line studies, anti-proliferative pathway investigations Cardiovascular metabolic pathway research homocysteine, SIRT activity, NF-B and STAT3 inflammatory signalling Comparative NNMT inhibitor studies 5-Amino-1MQ vs
Potential Benefits: Enhanced Detoxification: Supports the body's natural detoxification processes, helping to cleanse the body of harmful substances
30 A 2021 meta-analysis on the effects of B12 on cognitive function found no benefit with either B12 alone (based on four RCTs) or B12 combined with other B vitamins (based on 13 studies)
